Cytomegalic Inclusion Disease Overview
Learn About Cytomegalic Inclusion Disease
Sallie Permar is a Pediatric Infectious Disease specialist and an Infectious Disease provider in Durham, North Carolina. Dr. Permar has been practicing medicine for over 21 years and is rated as an Elite provider by MediFind in the treatment of Cytomegalic Inclusion Disease. Her top areas of expertise are Cytomegalovirus Infection, Congenital Cytomegalovirus, Cytomegalic Inclusion Disease, and HIV/AIDS.
Duke Health Integrated Practice Inc
Matthew Ellis is a Nephrologist and a Hospital Medicine provider in Burlington, North Carolina. Dr. Ellis and is rated as a Distinguished provider by MediFind in the treatment of Cytomegalic Inclusion Disease. His top areas of expertise are Cytomegalic Inclusion Disease, Cytomegalovirus Infection, End-Stage Renal Disease (ESRD), and Nephrosclerosis. Dr. Ellis is currently accepting new patients.
Duke Health Integrated Practice Inc
Rachel Miller is an Infectious Disease provider in Durham, North Carolina. Dr. Miller has been practicing medicine for over 36 years and is rated as an Advanced provider by MediFind in the treatment of Cytomegalic Inclusion Disease. Her top areas of expertise are Cytomegalovirus Infection, Cytomegalic Inclusion Disease, Nocardiosis, and Actinomycosis. Dr. Miller is currently accepting new patients.
Summary: This is a Phase 1 single-arm open-label study of letermovir in neonates with symptomatic congenital Cytomegalovirus (CMV) disease. There will be two groups enrolled. Group 1 will be comprised of 4 subjects. Following documentation study inclusion and signing of informed consent, Group 1 subjects will receive one dose of oral letermovir (Study Day 0), using the dose bands. A full pharmacokinetics (...
Summary: The objectives of the protocol are to determine if a structured cognitive-behavioral interventional counseling of pregnant women can limit acquisition of human cytomegalovirus (HCMV) during pregnancy that we believe, will in turn decrease the incidence of congenital HCMV infections in this highly seroimmune population. Previously, investigators have demonstrated the success of a similar approach i...